title: TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain.
abstract: BACKGROUND
  Transforming growth factor-beta (TGF-beta) is a causal factor in experimental glomerulosclerosis, and it mediates the increased extracellular matrix (ECM) accumulation that occurs in cultured mesangial cells (MCs) exposed to high glucose concentrations and cyclic mechanical strain. This change is associated with increased levels of TGF-beta, but may also involve alterations in receptor expression and binding.
  
  
  METHODS
  Rat MCs cultured in media containing either 8 or 35 mM glucose were seeded into culture plates with elastin-coated flexible bottoms. Thereafter, they were subjected to cyclic stretch or static conditions and then examined for 125I-TGF-beta1 binding and expression of TGF-beta receptors at the gene and protein levels.
  
  
  RESULTS
  Kinetic studies showed that MCs bound TGF-beta1 in a time- and concentration-dependent manner, expressing 6800 high-affinity receptors per cell, with an apparent dissociation constant (Kd) of 15.4 pM, while cross-linking analysis identified three TGF-beta receptors (betaR) corresponding to betaRI, betaRII, and betaRIII of 54, 73, and 200 kDa, respectively. Immunocytochemical studies of betaRI and betaRII protein revealed MC expression in a homogeneous, punctate distribution, whereas Northern analysis demonstrated the presence of the corresponding mRNAs. Exposure to cyclic stretching significantly increased (10%) the overall number of TGF-beta receptors, whereas ligands associated with betaRs I, II, and III also increased (25 to 50%). The finding of increased (30 to 40%) betaRI and betaRII transcript levels and immunoreactive protein (163 and 59%, respectively) in the absence of significant changes in the apparent Kd indicated that stretch-induced binding was the result of increased receptor synthesis and expression and not due to a change in binding affinity. In a similar, but more dramatic fashion, exposure to high glucose also elevated (50%) the receptor number, as well as the amount of ligands associated with betaRs I, II, and III (100 to 250%). This same treatment also increased the levels of betaRI and betaRII mRNA (30 to 40%) and the immunoreactive protein (82 and 82%, respectively), without significantly altering the binding affinity of the receptor. A concerted or synergistic effect of both stimuli was not evidenced.
  
  
  CONCLUSIONS
  These results suggest that the modulation of TGF-beta receptors may be an additional control point in mediating the glucose- and mechanical force-induced increase in ECM deposition by MCs.
authors.affiliation: Department of Internal Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan 48202, USA. riserb@usa.net
authors.forename: B L
authors.initials: BL
authors.lastname: Riser
authors.forename: S
authors.initials: S
authors.lastname: Ladson-Wofford
authors.forename: A
authors.initials: A
authors.lastname: Sharba
authors.forename: P
authors.initials: P
authors.lastname: Cortes
authors.forename: K
authors.initials: K
authors.lastname: Drake
authors.forename: C J
authors.initials: CJ
authors.lastname: Guerin
authors.forename: J
authors.initials: J
authors.lastname: Yee
authors.forename: M E
authors.initials: ME
authors.lastname: Choi
authors.forename: P R
authors.initials: PR
authors.lastname: Segarini
authors.forename: R G
authors.initials: RG
authors.lastname: Narins
mesh_terms: D030201:Activin Receptors, Type I; D000818:Animals; D015152:Blotting, Northern; D002478:Cells, Cultured; D003432:Cross-Linking Reagents / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004548:Elasticity; D005109:Extracellular Matrix / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D005920:Glomerular Mesangium / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology*; D007457:Iodine Radioisotopes; D007700:Kinetics; D011485:Protein Binding / Q000187:drug effects; D017346:Protein Serine-Threonine Kinases / Q000032:analysis / Q000235:genetics* / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344; D000077293:Receptor, Transforming Growth Factor-beta Type I; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000032:analysis / Q000235:genetics* / Q000378:metabolism*; D013314:Stress, Mechanical
chemical_list: D003432:Cross-Linking Reagents; D007457:Iodine Radioisotopes; D012333:RNA, Messenger; D018125:Receptors, Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D030201:Activin Receptors, Type I; D000077293:Receptor, Transforming Growth Factor-beta Type I; D000077294:Receptor, Transforming Growth Factor-beta Type II; C000625843:Tgfbr1 protein, rat; D005947:Glucose